Navigation Links
Results From Neurotech's NT-501 Phase 2 Retinitis Pigmentosa Studies Demonstrate Consistent Biological Effect on Photoreceptors
Date:5/28/2009

LINCOLN, R.I., May 28 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc. today announced that the Company's product candidate, NT-501, demonstrated a strong biologic effect in two Phase 2 clinical trials for retinitis pigmentosa (RP). RP is a slowly developing condition that causes the progressive degeneration of rod & cone photoreceptor cells in the retina that over time diminishes night and peripheral vision and eventually leads to blindness. RP is an orphan-designated indication for which there are currently no approved treatments.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090528/NE23594LOGO )

In both studies, there was a statistically significant (p< 0.001 for the high dose group in each study), dose-dependent increase in retinal thickness involving photoreceptor layers as measured by optical coherence tomography (OCT). This statistically-significant effect has also been observed in a recently completed Phase 2 NT-501 study in patients with geographic atrophy associated with dry age-related macular degeneration (AMD), the results of which were reported by Neurotech on March 26, 2009. This effect, which is believed by the Company to be neuroprotective, has also been demonstrated in animals.

NT-501 is an intraocular implant that consists of human cells that have been genetically modified to secrete ciliary neurotrophic factor (CNTF). CNTF, a growth factor capable of rescuing and protecting dying photoreceptors, is delivered directly to the back of the eye in a controlled, continuous basis by means of the Company's proprietary Encapsulated Cell Technology (ECT) platform. Delivery via ECT bypasses the blood-retinal barrier and overcomes a major obstacle in the treatment of retinal disease.

T
'/>"/>

SOURCE Neurotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results
2. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
3. Martek to Announce Second Quarter 2009 Results
4. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
5. Resverlogixs Success in Inflammation Program Results in 2 Patents Filed
6. Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business
7. Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results
8. China Biologic Products Announces Strong First Quarter 2009 Results
9. China Dasheng Biotechnology Company Reports Unaudited Third Quarter FY2009 Financial Results
10. China Biologic Products Announces 2009 First Quarter Results Conference Call
11. PharmAthene Reports First Quarter 2009 Financial and Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Emerson ... announced that Dr. Charles Signorino, the Company’s Chief Executive ... 1, 2013 after 32 years of service. As part ... Emerson’s current President, has been named as Dr. Signorino’s ... in the pharmaceutical industry, having made a significant contribution ...
(Date:5/21/2013)... MN (PRWEB) May 21, 2013 Revolutionary ... patented automatic colony counter, announced today that they have ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... and sophistication are especially useful in food microbiology and ... given an updated look. A bright white enclosure ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2
... New research suggests that some patients develop a potentially ... bacterial cells in their bodies have gene mutations that ... with implants can develop infections because of a biofilm ... devices. Researchers found that some strains of the bacteria, ...
... electronic and mechanical effects occurring in devices and ... are being investigated by researchers around the world. ... the generation of light, optical sensing, and information ... in physics and applications in this area, the ...
... (Nasdaq: CELG: $68) has been picked by S&P Capital ... carries S&P Capital IQ,s highest investment recommendation of 5-STARS, ... be among the best positioned biotechs for long-term growth, ... Equity Analyst at S&P Capital IQ.  "We believe the ...
Cached Biology Technology:Study offers clues as to why some patients get infections from cardiac implants 2Study offers clues as to why some patients get infections from cardiac implants 3Study offers clues as to why some patients get infections from cardiac implants 4Study offers clues as to why some patients get infections from cardiac implants 5Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures 2Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures 3Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures 4Optics Express Focus Issue: Collective phenomena in photonic, plasmonic and hybrid structures 5S&P Capital IQ Picks Celgene Focus Stock of the Week 2S&P Capital IQ Picks Celgene Focus Stock of the Week 3
(Date:5/21/2013)... a class of pharmaceuticals can both prevent and treat ... as "TSPO ligands," are currently used for certain types ... TSPO ligand in young adult mice when pathology was ... pathology was quite severe," said lead researcher Christian Pike ... reduced measures of pathology and improved behavior at both ...
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... stores, phosphatidylserine is a natural food supplement produced ... cognition and slow memory loss, it,s a popular ... a team headed by Prof. Gil Ast and ... of Human Molecular Genetics have discovered ... genes involved in degenerative brain disorders, including Parkinson,s ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2MU researchers develop radioactive nanoparticles that target cancer cells 2Common food supplement fights degenerative brain disorders 2
... research team has discovered that protein competition over ... different signals that direct early embryonic development. The ... before they interact with the organism,s DNA, as ... therapeutic strategies to fight cancer. The fought-over ...
... obstacle to the dream of virtually limitless yields of staple ... those plants on sexual reproduction. When male and female ... a genetically unique seed, valuable parental traits painstakingly selected by ... could be engineered to reproduce asexually -- an abilty of ...
... 8, 2010 Americans recognize things need to change in ... overhaul what is included in their food and on the ... for making the right food choices to avoid obesity, but ... to a new survey by FoodMinds. "In light of ...
Cached Biology News:Chemical competition: Research identifies new mechanism regulating embryonic development 2Chemical competition: Research identifies new mechanism regulating embryonic development 3Chemical competition: Research identifies new mechanism regulating embryonic development 4CSHL-Mexican team coaxes sexually reproducing plant to brink of asexual reproduction 2Americans want Uncle Sam's help putting healthy foods on their dinner table 2
Rabbit polyclonal to FANCG ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSRQTTSVGSSC, corresponding to amino acids 1 - 12 of Human FANCG. Entrez GeneID: 2189 Swis...
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6...
...
...
Biology Products: